↓ Skip to main content

Novel Nanostructured Lipid Carrier Co-Loaded with Doxorubicin and Docosahexaenoic Acid Demonstrates Enhanced in Vitro Activity and Overcomes Drug Resistance in MCF-7/Adr Cells

Overview of attention for article published in Pharmaceutical Research, February 2014
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
68 Dimensions

Readers on

mendeley
63 Mendeley
Title
Novel Nanostructured Lipid Carrier Co-Loaded with Doxorubicin and Docosahexaenoic Acid Demonstrates Enhanced in Vitro Activity and Overcomes Drug Resistance in MCF-7/Adr Cells
Published in
Pharmaceutical Research, February 2014
DOI 10.1007/s11095-013-1290-2
Pubmed ID
Authors

Samuel V. Mussi, Rupa Sawant, Federico Perche, Mônica C. Oliveira, Ricardo B. Azevedo, Lucas A. M. Ferreira, Vladimir P. Torchilin

Abstract

To develop a nanostructured lipid carrier (NLC) co-loaded with doxorubicin and docosahexaenoic acid (DHA) and to evaluate its potential to overcome drug resistance and to increase antitumoral effect in MCF-7/Adr cancer cell line.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 63 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 1 2%
Poland 1 2%
Unknown 61 97%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 11 17%
Student > Ph. D. Student 8 13%
Researcher 7 11%
Student > Postgraduate 6 10%
Professor > Associate Professor 4 6%
Other 12 19%
Unknown 15 24%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 21 33%
Medicine and Dentistry 4 6%
Engineering 4 6%
Agricultural and Biological Sciences 2 3%
Physics and Astronomy 2 3%
Other 11 17%
Unknown 19 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 December 2014.
All research outputs
#20,245,139
of 22,772,779 outputs
Outputs from Pharmaceutical Research
#2,641
of 2,855 outputs
Outputs of similar age
#271,076
of 313,560 outputs
Outputs of similar age from Pharmaceutical Research
#32
of 34 outputs
Altmetric has tracked 22,772,779 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,855 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 313,560 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 34 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.